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Abstract
Fifty-ﬁve episodes of bacteraemia arising in patients with a permanent endocardial pacemaker (PEP), from May 1987 to March 2006,
were reviewed to determine whether clinical and microbiological data might assist in individual clinical management. Episodes of PEP-
related bacteraemia were divided into early-onset bacteraemia, occurring within 6 months after device implantation or manipulation,
and late-onset bacteraemia, occurring thereafter. Episodes with a source different from the PEP were classiﬁed as out-of-system bacter-
aemia. The PEP was the source of infection in 27 (49%) patients. Among patients with early-onset PEP-related bacteraemia (n = 16),
Staphylococcus aureus was isolated in 87.5% (14/16) of cases; 81% of them (13/16) had local signs of infection at the PEP pocket and 25%
(4/16) died. Conversely, patients with late-onset PEP-related bacteraemia (n = 11) had a protracted clinical course; local signs of infec-
tion were infrequently observed (18%); a coagulase-negative staphylococcus was isolated in 91% of cases, and no death-related infection
was registered. In patients with out-of-system bacteraemia (n = 28), the device became colonized and required explantation in 56%
(5/9) of patients with S. aureus infection; the remaining 19 patients with out-of system bacteraemia caused by a microorganism other
than S. aureus were successfully managed with medical treatment. Early-onset and late-onset PEP-related bacteraemia differ regarding
the microorganism involved, the clinical presentation, and the prognosis. When the pacing system is involved, a complete explantation
of the device is necessary to cure the infection. However, most episodes of bacteraemia arising outside the PEP, mainly those not
caused by S. aureus, can be conservatively managed.
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Introduction
Infection is a serious complication of permanent endocardial
pacemaker (PEP) implantation [1,2]. Striking differences
regarding the incidence (0.19–20%), management and
prognosis of PEP-related infections have been reported, and
may be partially explained by the confusing terminology
[1–5]. Conditions such as erosions [6,7], generator-pocket
infection (local infection), wire infection, PEP-related
endocarditis and PEP-related bacteraemia are often grouped
together under the term ‘pacemaker infections’ [2].
Nevertheless, each of these entities has different clinical
manifestations and prognosis, and might require an individual
therapeutic approach [8]. In addition, most of the available
data on PEP-related infections have been reported from
referral centres in patients with infective endocarditis [9–14].
Little information is available regarding the characteristics
and management of bacteraemia occurring in patients bearing
a PEP [15–18]. The diagnostic approach and management of
these patients is a clinical challenge because it is often difﬁcult
to ascertain whether the pacemaker is the source of infection or
whether the device has been affected from a remote source.
In the present study, we attempted to clarify whether
differences in the time elapsed between PEP implantation or
manipulation and the onset of bacteraemia, and differences
regarding the microorganism isolated and the source of
infection, are clinically useful for individualizing the
management of bacteraemia arising in patients bearing a PEP.
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Materials and Methods
All PEP-bearing patients with an episode of signiﬁcant
bacteraemia, who were admitted to our hospital from May
1987 to March 2006, were included in the analysis. From
May 1987 to January 1997, clinical and microbiological data
were retrospectively collected by medical chart review.
Thereafter, a prospective clinical protocol was set up for the
evaluation of patients in whom the diagnosis of PEP infection
was entertained, which included blood cultures (two to
three sets of blood cultures drawn at intervals of 20–30 min
before starting antimicrobial therapy); culture of pus
obtained by ﬁne-needle aspiration or spontaneous pocket
drainage, and culture of the generator and wire tips when
the PEP was explanted.
Over the study period, 2503 PEP were implanted at the
Arrhythmia Unit of Complejo Hospitalario Xeral-Cı´es, a
university-afﬁliated referral centre for anti-arrhythmic
devices. After PEP implantation, patients were followed-up
every 3–6 months at the Arrhythmia Unit. The median
follow-up time was 8.6 years (range: 1 day to 12.2 years).
The study protocol was approved by the Ethics Committee.
Deﬁnitions
Clinically signiﬁcant bacteraemia: This was deﬁned as: (i) more
than one blood culture was positive for the same
microorganism or (ii) in patients with a single blood culture,
the same microorganism was isolated from an identiﬁed
source and/or there was clinical evidence of infection [19].
Relapse: A new episode of bacteraemia caused by the
same microorganism within 6 weeks of completing therapy.
Pacemaker-related bacteraemia: The PEP was considered as
the source of infection when: (i) there were signs of genera-
tor pocket infection (erythema, swelling, ﬂuctuation or
purulent drainage) and pus culture yielded the same micro-
organism as that isolated from blood cultures; (ii) signs of
pocket infection were absent but culture of the explanted
generator yielded the same microorganism as isolated from
the blood; or (iii) none of the previous criteria were met but
the patient fulﬁlled diagnostic criteria for PEP-associated
deﬁnite endocarditis [8,15].
Early-onset bacteraemia related to the pacing system:
Bacteraemia occurring within 6 months after PEP
implantation or device manipulation.
Late-onset bacteraemia related to the pacing system:
Bacteraemia diagnosed later than 6 months after PEP implan-
tation or manipulation.
Out-of-system bacteraemia: Bacteraemia was considered to
have originated from a source other than the PEP in patients
who did not meet any of the criteria for PEP-related bactera-
emia and another source was identiﬁed. We assumed that the
pacemaker was not infected when bacteraemia did not relapse
within 6 months after completion of antibiotic therapy.
Infective endocarditis: To increase the accuracy of the
original Duke criteria for the diagnosis of PEP-related
endocarditis [20], the diagnosis of infective endocarditis was
deﬁned according to the modiﬁed Duke criteria [21] and the
criteria for pacemaker lead-associated endocarditis were
those proposed by Klug et al. [11]. Only patients fulﬁlling
criteria for deﬁnite endocarditis were considered to have
infective endocarditis.
Statistical analysis
Quantitative variables are expressed as median and
interquartile ranges (IQR) and were compared using the
Mann–Whitney U-test. Qualitative variables are expressed as
percentages and were compared using the chi-square test or
Fisher’s exact test. The strength of association between
variables is expressed as risk ratio (RR) and 95% CI.
Results
During the study period, 55 patients with signiﬁcant
bacteraemia were identiﬁed.
Bacteraemia arising from the pacing system (n = 27). All but
one patient had fever, with a median temperature of 38.8C
(range: 37.5–40.0C). The median C-reactive protein level
was 88 mg/dL (range: 15–249 mg/dL), and the median
leukocyte count was 13 789 · 106 cells/mm3 (range: 3160–
27 100 · 106 cells/mm3).
Characteristics of patients with PEP-related early-onset bactera-
emia (n = 16). Infection occurred within the ﬁrst month in
75% (12/16) of patients and staphyloccocal bacteraemia
occurred in 87.5% (14/16) of them (Table 1). Overall, signs
of generator pocket infection were present in 81.2% (13/16),
and in 93% (13/14) of patients with S. aureus bacteraemia.
The PEP was extruded in 15 cases, in all but one by external
traction. Four (25%) patients died, in three cases after PEP
explantation, because of septic shock. Among the survivors,
25% (3/12) did not require further pacing therapy (Table 1).
Characteristics of patients with PEP-related late-onset
bacteraemia (n = 11). The presence of local infection signs
prompted the diagnosis of PEP-associated bacteraemia in
two patients (Table 2). In the remaining nine patients, a
lengthy diagnostic work-up was required to uncover the
PEP-related infection. Coagulose-negative staphylococci were
isolated in 91% of cases and 80% (8/10) of these were methi-
cillin-sensitive. It is worth noting that 45% of these patients
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(5/11) had been admitted to hospital with a diagnosis of
community-acquired pneumonia. In all these cases, a coagu-
lase-negative staphylococci (CNS) bacteraemia was initially
considered to be blood culture contamination. Characteristi-
cally, these patients responded well to antibiotic therapy.
However, fever recurrence was the rule once antibiotics
were discontinued.
External traction was unsuccessfully tried in nine patients,
and eight of them eventually underwent thoracotomy with
implantation of an epicardial pacing system. Surgical











culture TTE TEE Extraction/outcome
Follow-up
(days)
1 M/57 121 MSSA MSSA ND ND ND Yes/cured 30b
2 F/57 26 MSSA MSSA ND ) ND Yes/cured 4899b
3 F/82 94 MSSA MSSA ND ND ND Yes/died 3
4 F/76 7 MSSA MSSA ND ) ND Yes/cured 3094c






ND ) ND Yes/died 27
6 F/71 3 MSSA MSSA ND ND ND No/died 1




ND ) ND Yes/cured 668




) +/sleeve Yes/cured 1984c
9 M/78 4 MSSA MSSA MSSA ) ) Yes/cured 1422c
10 M/83 16 MSSA MSSA Negative ) ND Yes/died 15
11 F/72 11 MSSA MSSA MSSA ) ) Yes/cured 1418
12 M/83 16 MSSA MSSA Negative ) ) Yes/cured 1323b
13 F/80 17 MSSA MSSA + MS
Staphylococcus hominis
Negative ) ) Yes/cured 1246
14 M/80 16 MSSA MSSA MSSA + +/vegetation Yes/cured 1234
15 M/81 9 MSSA MSSA ND ) ) Yes/cured 622
16 M/85 156 MSSA +
MSSE +
Enterococcus faecalis
MSSA + MSSE MSSE ) +/vegetation Yes/cured 155c
F, female; M, male; MSSA, Methicillin-sensitive Staphylococcus aureus; MSSE, Methicillin-sensitive Staphylococcus epidermidis; MRSE, Methicillin-resistant S. epidermidis; ND, not
done; TTE, transthoracic echocardiography; TEE, transoesophageal echocardiography; +, ﬁndings suggesting infectious endocarditis (sleeve or vegetations); ), no ﬁndings sug-
gesting infectious endocarditis.
aTime elapsed between permanent endocardial pacemaker (PEP) manipulation and bacteraemia.
bPacing was not further required.
cDeath not related to PEP infection.











culture TTE TEE Extraction/outcome
Follow-up
(days)
1 M/56 74.7 MRSE MRSE MRSE ) ND Yes/cured 119b






) ND Yes/cured 739c






) ND Yes/cured 725c
4 F/18 50.7 MSSE MSSE MSSE ) +/vegetation Yes/cured 2843






) +/vegetation Yes/cured 1116c
6 F/80 73.5 Enterococcus cloacae Enterococcus cloacae Enterococcus cloacae + +/vegetation Yes/cured 636
7 F/81 32.2 MSSE ND ND + +/vegetation No/suppressive
ATB
656c
8 M/78 32.2 MSSE MSSE MRSE + +/vegetation Yes/cured 1803c
9 M/63 45.8 MSSE Sterile Sterile + +/vegetation Yes/cured 469
10 F/81 40.2 MR Staphylococcus simulans ND ND + ND No/suppressive ATB 247c
11 M/77 68 MRSE MRSE MRSE ) +/sleeve Yes/cured 875
ATB, antibiotic therapy; F, female; M, male; MSSE, Methicillin-sensitive Staphylococcus epidermidis; MRSE, Methicillin-resistant S. epidermidis; ND, not done; +, ﬁndings suggesting
infectious endocarditis (sleeve or vegetations); ), no ﬁndings suggesting infectious endocarditis; mo, months.
bPacing was not further required.
cDeath not related to permanent endocardial pacemaker infection.
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explantation was initially rejected in ﬁve patients, all of whom
had a coagulase-negative staphylococcal bacteraemia; in three
patients because the PEP was considered not to be the
infection source; and in the other two patients because of
the surgical risk. The former three patients treated
conservatively relapsed after an 8–12-week course of
antibiotic therapy with rifampicin plus levoﬂoxacin, and
eventually underwent successful surgical pacemaker removal.
The latter two patients remained on suppressive therapy
without relapse until death due to unrelated causes 247 days
and 656 days after the diagnosis (Table 2).
Differences between early-onset and late-onset PEP-related
bacteraemia. Staphylococcus aureus and CNS were,
respectively, the microorganisms most frequently isolated
from blood culture in the two groups. All 11 patients with
late-onset bacteraemia fulﬁlled the diagnostic criteria for
deﬁnite endocarditis compared to 62.2% (5/8 who completed
the diagnostic work-up) of patients in the early-onset group
(RR 1.60; 95% CI 0.94–2.74). With respect to the
transoesophageal echocardiography (TEE) diagnostic perfor-
mance for infective endocarditis, a trend for a lower sensitiv-
ity was observed in patients with early-onset bacteraemia
(3/5; 60%) compared to patients with late-onset bacteraemia
(7/7) (RR, 0.6; 95% CI, 0.29–1.23). In all cases, the
vegetations were attached to the wire tip, and the tricuspid
valve was additionally involved in one case. Related mortality
was 25% (4/16) among patients with early-onset bacteraemia,
whereas no death-related infection was registered in the
late-onset group (Table 3).
Out-of-system bacteraemia (n = 28). The device was
removed because of wire involvement in ﬁve (55.6%) of nine
patients with S. aureus bacteraemia (Table 4). Infection-
related death occurred during antibiotic treatment in an
89-year-old man prior to PEP removal. The remaining three
patients received antimicrobial therapy alone and were
closely followed without evidence of relapse.
No PEP-related CNS bacteraemia was recorded in ﬁve
patients. The source of infection was a venous catheter
(n = 3) and prosthetic valve endocarditis (n = 2). One
patient underwent valve replacement plus PEP extraction
and reimplantation of an epicardial pacemaker; however, no
signs of wire-associated endocarditis were seen at TEE, and
culture of the explanted PEP was negative. The remaining
four patients received only antimicrobial therapy and were
followed over a median of 758 days (range: 225–1292 days)
without evidence of relapse.
Non-staphylococcal Gram-positive bacteraemia occurred
in seven patients (Streptococcus mitis in two, and Enterococcus
durans, Enterococcus faecalis, Streptococcus bovis, Streptococcus
mutans and Streptococcus salivarius in one each). Deﬁnite left-
sided endocarditis was the source of bacteraemia in six
cases, but none of them showed signs of wire infection at
TEE study. All patients were conservatively managed and
had a good outcome after a 4-week course of antibiotic
treatment.
One episode of candidemia (Candida albicans) was
recorded in a patient receiving parenteral nutrition. The TEE
study was normal, and the patient was treated with a 14-day
course of intravenous ﬂuconazole. There was no evidence of
relapse up to the time of his death, due to an unrelated
cause, 32 months later. Gram-negative bacillary bacteraemia
occurred in six patients (Escherichia coli in four, and Klebsiel-
la pneumoniae, and Pseudomonas aeruginosa in one each). The
source of infection was the urinary tract (n = 5) and a
peripheral venous catheter (n = 1). Transthoracic echocardi-
ography examination in four cases and TEE in the other two
were normal and no relapse was documented over a median
follow-up of 859 days (range: 386–2513 days).
Discussion
There is no general consensus on the timing-based classiﬁca-
tion of PEP-associated bacteraemia [1,4,9,12–14,16,22]. Most
early-onset episodes occur, as observed in our series, during
the ﬁrst 30 days after device implantation or invasive
manipulation. We chose a cut-off point of 6 months for the
deﬁnition of early-onset bacteraemia, because episodes
occurring between 3 and 6 months, which some studies
classify as intermediate-onset bacteraemia, are infrequent
and share clinical and microbiological characteristics with the
early-onset group [4,5,13,15]. Furthermore, after 6 months,
ﬁbrous tissue can ﬁrmly trap the wire to the endocardium,
making external traction risky [23,24]. In keeping with
previous studies [9,13,15,16], S. aureus was responsible for
early-onset bacteraemia in 87.5% of patients and signs of
TABLE 3. Differences between early-onset and late-onset




(n = 11) p-value
Age (years) 80.0 (71.8–83.2) 77.5 (57.5–80.5) 0.1214
Sex, male 9 (56.3%) 7 (63.6%) 1
Local signs of infection 13/16 (81.2%) 2/11 (18.2%) 0.0052
Blood culture
Staphylococcus aureus 14 (87.5%) 0 <0.0001
CNS 2 (12.5%) 10 (91%) 0.0004
Infectious endocarditis 5/8 (62.5) 11 (100%) 0.1250
TEE sensitivity for
infectious endocarditis
3/5 (60%) 7/7 (100%)
Infection-related death rate 4 (25%) 0 0.2216
Continuous variables are expressed as median (interquartile range).
CNS, coagulase-negative staphylocci; 1 TEE, transoesophageal echocardiography.
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pocket infection prompting an early diagnosis of PEP-related
infection were present in 93%.
However, in agreement with previously reported data
[16], the pacemaker was frequently not the source of
infection in patients with late-onset S. aureus bacteraemia.
The sensitivity of TEE for the diagnosis of endocarditis in
patients with early-onset bacteraemia in the present study
was lower than the reported values from large series of
PEP-related endocarditis [9,11,13,14]. This difference could
be explained by a selection bias in those studies conducted
in patients fulﬁlling the diagnostic criteria for endocarditis,
and sent to a reference centre for evaluation for surgery. In
addition, a trend for a lower sensitivity of TEE was observed
in patients with early-onset bacteraemia compared to
patients with late-onset bacteraemia, most likely as a result
of the smaller vegetation size in the former group. However,
these data are limited by the small number of patients who
underwent a complete diagnostic work-up for infectious
endocarditis in the present study.
Coagulase-negative staphylococci, 80% of them methicillin-
sensitive, were isolated in 91% of patients with late-onset
bacteraemia.
These patients commonly present with fever, show no
signs of pocket infection, and are often misdiagnosed as
having urinary or respiratory tract infections [10,11]. Indeed,
when clinicians are unaware of this condition, CNS bactera-
emia may be considered as a culture contaminant [11,25].
Furthermore, in agreement with our experience, these
patients become rapidly asymptomatic under antibiotic
treatment and, consequently, delayed diagnoses and frequent
relapses are common. For these reasons, whenever fever
and lung consolidation are present in a patient bearing a PEP,
wire infection should be considered [11,26]. In this group,
the sensitivity of TEE for diagnosing PEP-related endocarditis
is greater than 90% [9,11,13,14].
Although there are no randomized trials comparing device
explantation with a conservative strategy in the management
of PEP-related bacteraemia, we agree with the ﬁndings
obtained in most studies indicating that complete PEP
removal is required for cure in patients with pacemaker wire
infection [4,8,10,11,14,15,25–28]. This makes particular sense
in patients with S. aureus bacteraemia, a life-threatening event
that should be aggressively managed by swift device removal
[9,15,16,22]. Cardiotomy has been classically recommended
for extraction in the late-onset group because the devices
have been in place for months or year. However, a laser-
assisted system might avoid surgical extraction in most cases
[4,29]. In our series, two patients with CNS bacteraemia and
wire-associated endocarditis received suppressive antibiotic
therapy until death by an unrelated cause. Nevertheless, this
conservative approach has a limited role in the management
of these patients and should be reserved only for those
patients who cannot tolerate any surgical procedure
[4,22,30,31].
In the present study, the bacteraemia source was outside
the PEP in 28 cases. However, because of the partially
retrospective nature of the present study and difﬁculties
involved in detecting episodes of transient bacteraemia, the
real incidence of bacteraemia arising out of the pacing system
was probably underestimated. By contrast to previous stud-
ies [17], the source of infection in the present study was
identiﬁed in all these patients.
The management of bacteraemia arising from a PEP is
controversial and strongly conditioned by the microorganism
isolated [12,15,17]. The study by Camus et al. [15] on
sustained bacteraemia in patients bearing a PEP includes 12
cases in which the source of infection was not the pacemaker.
All of the ﬁve patients with non-staphylococcal bacteraemia
were cured with antimicrobial treatment, whereas 71% (5/7)
of those with S. aureus bacteraemia had secondary wire
involvement, and PEP explantation was necessary for cure.
Chamis et al., [16] found a PEP wire colonization rate of
33.3% in S. aureus bacteraemia originating outside the pacing
system. In the present study, the pacemaker was colonized
TABLE 4. Out-of-system bactera-
emia caused by Staphylococcus
aureus
Sex/age Blood Infectious source TTE/TEE Extraction Outcome Follow-up (days)
F/73 MSSA Temporary pacemaker )/ND No Cured 1396b
M/89 MSSA Peripheral venous catheter )/ND No Died 59
M/56 MSSA Cutaneous ulcer )/) No Cured 78b
M/69 MSSA Perianal abscess )/ND Yes Cured 2716b
M/68 MSSA Leg wound +/+ Yes Cured 920ab
M/82 MRSA Peripheral venous catheter )/) Yes Cured 1174
M/60 MSSA Temporary pacemaker )/) No Cured 665
M/75 MRSA Cutaneous ulcer ± Yes Cured 198a
M/76 MRSA Aortic graft infection +/+ Yes Cured 107ab
M, male; F, female; MSSA, Methicillin-sensitive Staphylococcus aureus; MRSA, Methicillin-resistant S. aureus; ND, not
done; TTE, transthoracic echocardiography; TEE, transoesophageal echocardiography; +, ﬁndings suggesting infectious
endocarditis (sleeve or vegetations); ), no ﬁndings suggesting infectious endocarditis.
aPacing was not further required.
bDeath not related to permanent endocardial pacemaker infection.
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and required removal in 56% (5/9) of patients with S. aureus
bacteraemia arising out-of-system, whereas the remainder
were cured with antimicrobial treatment.
In agreement with Chamis et al., [16] we believe that
patients with S. aureus bacteraemia unrelated to the pace-
maker can be conservatively managed if there is no
prolonged fever or persistently positive blood cultures,
provided that the TEE examination is normal. Finally,
unlike Arber et al., [12], we did not observe wire coloni-
zation in 12 patients with Gram-positive non-S. aureus
bacteraemia, nor in six patients with Gram-negative bacter-
aemia or in one episode of candidaemia unrelated to the
device, and all these patients had a favourable outcome on
antimicrobial therapy. Our data support conservative
treatment in these patients, together with close follow-up
for at least 6 months to rule out wire infection [15,17,18].
In conclusion, early-onset and late-onset PEP-related
bacteraemia and out-of-system bacteraemia show relevant
differences in aetiology, difﬁculty of diagnosis, and prognosis.
Knowledge of these differences may be useful for the
management of bacteraemia occurring in patients bearing a
PEP. An approach based on the timing of the infection, the
microorganism isolated and certitude about the source of
infection might shorten the diagnostic work-up, and provide
the rationale for individually-tailored treatment, avoiding
removal of the pacing system in patients with out-of-system
bacteraemia who are at low risk for secondary wire
infection.
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